Prostate cancer Board decisions

The Veteran's claim for an increased evaluation for radial nerve peripheral neuropathy, left upper extremity was denied. The claims for service connection for prostate cancer, coronary artery disease (CAD), right lower extremity neuropathy, and left lower extremity neuropathy were granted based on new and relevant evidence submitted after the August 2019 denial.

The Veteran's prostate cancer and lung cancer are granted as service connection is established due to presumed exposure to herbicides in Vietnam.,Service connection for voiding dysfunction, erectile dysfunction (ED), and sleep apnea are also granted as these conditions are found to be secondary to the service-connected prostate cancer.

Service connection for prostate cancer is granted under the PACT Act, and service connection for bladder cancer is remanded.

The Veteran's claims for service connection for an acquired psychiatric disorder (including PTSD) and prostate cancer were denied. The claim for prostate cancer was remanded due to the need for additional evidence regarding herbicide agent exposure.

The Board has remanded the claims for service connection for a pancreas condition, prostate cancer, glaucoma, macular pigment change, and age-related cataract (claimed as latanoprost of the left eye), and diabetes mellitus due to duty assist errors. A VA medical opinion is needed regarding the etiology of these conditions.

The Veteran's claims for service connection for an acquired psychiatric disorder (including PTSD) and prostate cancer are denied. The claim for prostate cancer is remanded due to the need for additional evidence regarding herbicide agent exposure.

The Veteran's initial ratings for diabetes mellitus and prostate cancer have been granted, with a 40 percent rating assigned for each condition. The effective dates are not specified as the claims were initially filed on November 28, 2016.

The Board has remanded the issues of whether the discontinuance of the 100 percent evaluation for prostate cancer effective January 1, 2019, was proper and entitlement to a disability rating in excess of 40 percent for prostate cancer from January 1, 2019. The Veteran needs to provide VA with his treatment records and undergo a VA examination.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents in Vietnam. The heart condition issue is remanded for further examination and opinion.

The Board has granted a 40% disability rating for prostate cancer residuals, effective May 1, 2022. The reduction of the initial 100% rating was proper as the Veteran is currently in remission and no longer receiving treatment.

The Veteran's service-connected disabilities do not render him unable to obtain or maintain gainful employment, and his claim for TDIU is denied.

The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents during his service at Korat RTAFB under the PACT Act and thus meeting the criteria for presumptive service connection.

The Veteran's claims for effective dates prior to February 28, 2014 (bilateral hearing loss) and January 31, 2018 (CAD) are denied.,The Veteran's claim for an effective date prior to January 31, 2018 for TDIU is denied as there was no formal or informal claim filed before that date.

The Board has granted service connection for benign prostatic hypertrophy, left knee disability, right knee disability, gastritis, and bilateral onychomycosis and tinea pedis of the feet. The claims were previously remanded due to conflicting medical opinions.

The Board has remanded the case due to insufficient medical opinions regarding the severity of the Veteran's prostate cancer during a specific period.

The Veteran's prostate cancer residuals are rated at a 40 percent rating since September 16, 2022. The appeal for a higher rating is denied. SMC under 38 U.S.C. § 1114(s) from January 1, 2019 is also denied.

The Board has remanded the Veteran's claims for additional development due to non-compliance with previous remand directives.

The Veteran's initial ratings for PTSD with mood disorder and residuals of prostate cancer were denied, and the case was remanded to obtain additional evidence.,Service connection for hypertension was granted based on presumed exposure to herbicide agents.

The Veteran's eligibility for PCAFC benefits was denied due to lack of personal care services. The Board has decided the case is remanded as there are outstanding development tasks, including an in-home assessment and caregiver training.

The Board has decided that the reduction in the disability rating for prostate cancer residuals from 100 percent to 20 percent, effective May 1, 2020, was improper and has remanded the case for further action.